HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 30, Issue 1, Pages 123-129 (March 2009)


View previous. 11 of 17 View next.

Coagulation Disorders in the ICU

Peter W. Marks, MD, PhDemail address

Disorders of hemostasis and thrombosis are frequently encountered in the ICU setting. Understanding the relevance of laboratory findings is essential in providing appropriate therapy. Various blood products and hemostatic agents are available to assist in the control of bleeding, and several different classes of anticoagulants are now available for use. Appropriate use of these agents maximizes therapeutic effect while minimizing complications. Use of fresh frozen plasma, cryoprecipitate, and other hemostatic agents should generally be reserved for those who have active bleeding, those undergoing invasive procedures, and those at high risk for bleeding because of their underlying diagnoses or because of associated hematologic derangements.

Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, LCI 100, P.O. Box 208021, New Haven, CT 06520, USA

PII: S0272-5231(08)00118-4

doi:10.1016/j.ccm.2008.11.003


View previous. 11 of 17 View next.